Home LiteratureArticle Details
PMID: 309485 Published · ppublish English Journal Article

In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 121 ·No. 5 ·1978-11-00 ·Pages 1951-5

Rosenberg SA, Schwarz S, Spiess PJ

Abstract

Growth factors (GM), produced by murine lymphoid cells incubated with Concanavalin A, have been used to grow cytotoxic lymphoid cells in culture. C57BL/6 and DBA/2 lymphoid cells were sensitized against each other in primary, secondary, and tertiary in vitro cultures. These sensitized cells were grown in vitro in GM and retained their cytotoxic properties. Cells grew in culture about 10-fold every 5 to 7 days for over 2 months. Initial growth of cytotoxic cells in GM resulted in marked enhancement of specific cytotoxicity that returned to original levels after subsequent subcultures. After five 10-fold cell culture generations some nonspecific cytotoxicity directed against the responding target cell strain appeared in continuous cultures. This technique for growing large numbers of cytotoxic cells may be of value in the development of adoptive immunotherapies.

MeSH Terms
Animals Culture Media Cytotoxicity, Immunologic Isoantigens Lymphocyte Activation Mice Mice, Inbred C57BL Mice, Inbred DBA Neoplasms, Experimental/immunology T-Lymphocytes/immunology Time Factors
Chemicals
Culture Media Isoantigens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rosenberg S A
Schwarz S
Spiess P J
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1978-11-00
Pages
1951-5
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com